PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 113 filers reported holding PTC THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $9,025,000 | +71.1% | 192,017 | +22.8% | 0.65% | +70.3% |
| Q2 2018 | $5,275,000 | +65.2% | 156,398 | +32.5% | 0.38% | +58.8% |
| Q1 2018 | $3,193,000 | +19.6% | 118,006 | -26.3% | 0.24% | +22.4% |
| Q4 2017 | $2,669,000 | -76.0% | 160,032 | -71.3% | 0.20% | -74.2% |
| Q3 2017 | $11,141,000 | -0.3% | 556,809 | -8.7% | 0.76% | -6.9% |
| Q2 2017 | $11,179,000 | +62.0% | 609,921 | -13.1% | 0.82% | +69.4% |
| Q1 2017 | $6,902,000 | -16.4% | 701,463 | -7.3% | 0.48% | -15.5% |
| Q4 2016 | $8,253,000 | -15.9% | 756,488 | +8.0% | 0.57% | -19.5% |
| Q3 2016 | $9,809,000 | +442.5% | 700,213 | +171.7% | 0.71% | +465.6% |
| Q2 2016 | $1,808,000 | +160.9% | 257,679 | +892.0% | 0.12% | +155.1% |
| Q3 2015 | $693,000 | -53.0% | 25,976 | -8.8% | 0.05% | -50.0% |
| Q4 2014 | $1,475,000 | – | 28,494 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
| Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
| ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
| COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
| GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
| SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
| Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
| Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |